Karyopharm Therapeutics I...

4.36
0.10 (2.35%)
At close: Apr 16, 2025, 3:59 PM
4.36
-0.02%
After-hours: Apr 16, 2025, 07:55 PM EDT

Karyopharm Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-76.42M -143.1M -165.29M -124.09M -196.27M -199.59M -178.41M -128.98M -109.58M
-2.16M 530K 621K 789K 972K 974K 735K 713K 717K
18.43M 21.71M 35.4M 29.78M 24.41M 15.29M 17.27M 20.41M 22.28M
n/a 9.76M -15.96M -9.26M 5.54M -1.8M 1.21M 32.05M 42K
-67.33M -3.28M -294K 8.13M 8.4M 7.19M 1.42M 1.19M 1.2M
n/a n/a n/a 1.45M 904K -1.38M 29K n/a n/a
n/a 31.41M -19.99M -23.19M 1.36M -13.31M -169K 32.96M 987K
-127.49M -92.72M -149.55M -107.12M -160.23M -190.82M -159.12M -73.72M -84.39M
-142K n/a -118K -5.71M -145K -206K -2.36M -62K -70K
n/a n/a 104.26M 5.5M 53.54M -78.66M n/a n/a n/a
-58.82M -159.15M -226.02M -45.23M -274.58M -178.49M -242.81M -98.37M -134.7M
154.44M 167.09M 121.88M 192.78M 221.04M 257.14M 137.51M 115.54M 159.37M
n/a n/a -104.26M -5.5M -53.54M 78.66M -105.3M 17.17M 24.66M
95.47M 7.94M -104.26M 141.84M -53.69M 78.45M -107.66M 17.11M 24.59M
83.3M n/a n/a n/a n/a n/a 166.88M n/a n/a
111M n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
-41.65M 1.12M 3.98M 63.74M 10.31M 78.11M 3.52M 858K 591K
41.65M 1.12M 193.74M 73.65M 172.08M 124.31M 316.11M 75.74M 51.16M
9.62M -83.69M -60.56M 108.32M -41.57M 11.95M 49.25M 19.33M -8.7M
-127.63M -92.72M -149.67M -112.83M -160.38M -191.03M -161.48M -73.78M -84.46M